5WA — OUE Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- SG$119.96m
- SG$1.07bn
- SG$159.32m
- 20
- 83
- 49
- 49
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.24 | -99.2 | 111 | 32.5 | 57.5 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -4.54 | 101 | -108 | 32.5 | 20.4 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.48 | -1.66 | -0.221 | -14.9 | -14.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.28 | 1.01 | 4.09 | 51.6 | 65.5 |
Capital Expenditures | -1.13 | -1.37 | -0.954 | -0.61 | -0.477 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -29.8 | 8.11 | -29 | 43.8 | -62.4 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -31 | 6.74 | -30 | 43.2 | -62.8 |
Financing Cash Flow Items | -2.6 | -2.91 | -3.11 | -66.2 | -61.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 27.3 | 7.79 | 2.03 | -67.9 | -8.09 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.73 | 16.3 | -25.1 | 23.1 | -7.26 |